Clinical trial NCT06599931: Cerebello-motor Neuromodulation After Stroke. CERSTIM.
Official title: CEREBELLO-MOTOR NEUROMODULATION AFTER STROKE
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Stroke
Healthy
Lead sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Sponsor class: OTHER_GOV
First posted: 2024-09-19
Enrollment: 45
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Intervention model description: Three sessions active tACS 20 minutes, 50Htz active tACS 20 minutes, 70 Htz sham

Order will be randomized
Primary purpose: BASIC_SCIENCE

Brief summary: The CERSTIM study is a physiopatholgical study investigating transcranial alternating current stimulation in stroke patients in the cerebello-motor loop.

The design is a cross over design testing two frequencies in the gamma band and one placebo.

We will use behavioural data, functional MRI, and Electroencephalography to disentangle the effect of tACS and its frequency.

Healthy participants will be also recruited.

Detailed description: Neuromodulation, by the means of Non-Invasive Brain Stimulation techniques, is a promising method to enhance motor recovery of the upper limb following a stroke. However, none of these techniques have yet been effectively transferred to the patient's bedside. An international group of experts has examined this issue, identifying barriers that need to be overcome for successful transferability. Among their findings, two were particularly emphasized: (i) the insufficient characterization of the mechanisms through which these stimulations are effective, and (ii) the comparison of stimulation parameters before moving on to larger samples. We have decided to use this model to study tACS (transcranial Alternating Current Stimulation) on the cerebellomotor network.

The choice of tACS is justified by (i) its ability to "entrain" a neural network through its oscillations, (ii) its innovative nature, and (iii) its "wearable" characteristic, making it quickly transferable. The choice of the cerebellomotor network is based on literature data showing that (i) the cerebellum plays a crucial role in motor learning in healthy individuals (which is one of the substrates of post-stroke recovery), and (ii) cerebellomotor synchronization is a good prognostic indicator for the recovery of hand motor function.

In light of these findings, we have decided to conduct a pathophysiological, bi-centric study to determine the cerebral mechanisms by which tACS acts on the cerebellomotor network. Three single sessions of tACS, each lasting 20 minutes, will be conducted 7-15 days apart, with a different frequency (50 or 70 Hz, corresponding to gamma oscillations) or a placebo frequency known as "sham." To understand the cerebral mechanisms, we will use Magnetic Resonance Imaging (MRI) and Electroencephalography (EEG). We will also examine a behavioral motor adaptation task on a tablet. The order in which the three frequencies are applied will be randomized This study will include 30 patients and 15 healthy subjects. The patients will be individuals who have suffered a stroke more than 6 months ago, resulting in a hand deficit without complete paralysis. The healthy controls will serve as a reference for mechanisms and imaging/electrophysiology data.

We hypothesize the following: The mechanisms involved following cerebellomotor stimulation could include a modification of brain rhythms in the beta or gamma band during movement, an increase in activity in the primary motor cortex, or a change in the excitation-inhibition balance between the cerebellum and the primary motor cortex, or directly at the level of the primary motor cortex. These different mechanisms may vary depending on the frequency used.

This research is part of the NEUROTECH Impulse Program managed by INSERM.

Eligibility criteria: PATIENTS

Inclusion Criteria:

* Male or female aged 18 years or older on the day of inclusion.
* Affiliated with a social security system, Universal Health Coverage (CMU), or any equivalent scheme.
* Ischemic stroke or intraparenchymal hematoma that occurred more than 6 months ago, with no upper time limit.
* Motor deficit of the upper limb confirmed by the ARAT scale, with the ability to grip and press on a tablet.
* stroke lesion not affecting the motor cortex in the hand knob area.

Exclusion Criteria:

-- Pregnant and breastfeeding women

* Total paralysis of the affected hand
* Conditions that are life-threatening or could compromise follow-up during the study period
* Contraindications to MRI and tACS (ferromagnetic surgical clips, ocular implants, intraocular or nervous system metallic foreign bodies, implants or metallic objects likely to concentrate the radiofrequency field, cochlear implants, brain or cardiac stimulators, presence of a craniotomy scar)
* Participation in another biomedical study focused on motor or overall recovery during the same period, or current exclusion period from another biomedical study

HEALTHY

Inclusion Criteria:

* Male or female aged 18 years or older on the day of inclusion.
* Affiliated with a social security system, Universal Health Coverage (CMU), or any equivalent scheme.

Non inclusion criteria

-- Pregnant and breastfeeding women

* Conditions that are life-threatening or could compromise follow-up during the study period
* Contraindications to MRI and tACS (ferromagnetic surgical clips, ocular implants, intraocular or nervous system metallic foreign bodies, implants or metallic objects likely to concentrate the radiofrequency field, cochlear implants, brain or cardiac stimulators, presence of a craniotomy scar)
* Participation in another biomedical study during the same period, or current exclusion period from another biomedical study

Primary outcomes:
measure: change in activation in the primary motor cortex and cerebellum using functional magnetic Resonance
timeFrame: [Time Frame: within 1 hour before and after the intervention]
Secondary outcomes:
measure: comparison between activation in the primary motor cortex and cerebellum using functional magnetic Resonance with the 50 Htz versus the 70 Htz frequency
timeFrame: [Time Frame: within 1 hour before and after the intervention]
measure: change in functional connectivity between the primary motor cortex and cerebellum using functional magnetic Resonance
timeFrame: [Time Frame: within 1 hour before and after the intervention]
measure: change in functional connectivity using EEG after intervention and comparison between frequencies of tACS
timeFrame: [Time Frame: within 1 hour before and after the intervention]
measure: change in behaviour after intervention and comparison between frequencies of tACS
timeFrame: [Time Frame: within 1 hour before and after the intervention]
measure: comparison of the prespecified patients outcome with those of healthy subjects
timeFrame: [Time Frame: within 1 hour before and after the intervention]
Other outcomes:
Locations:
city: Paris
country: France
facility: ICM_ Institut du Cerveau et de la Moelle épinière, Hôpital Pitié, 47 Bd de l'Hôpital
city: Toulouse
country: France
facility: ToNIC - Toulouse neuro Imaging center (Inserm)Pavillon Baudot
Study officials:
affiliation: Institut National de la Santé Et de la Recherche Médicale, France
name: Charlotte ROSSO, MD PHD
role: PRINCIPAL_INVESTIGATOR
References: